Among 8,184 adults without diabetes who initiated injectable semaglutide or tirzepatide for obesity, 4,492 had a dispensing gap longer than 90 days within the first year
The mechanistic hypothesis: Semaglutide activates GLP-1R, appetite suppression, glycemic control Cagrilintide activates amylin receptors, appetite suppression via the area postrema, slowing of gastric evacuation Two independent mechanisms of appetite suppression a supra-additive effect In Phase 1b and Phase 2 trials the combination showed a stronger effect than either component alone : Semaglutide alone: 14.9 % (STEP-1) Cagrilintide alone (Phase 2): 10.8 % CagriSema combination (Phase 2): 15.6 % CagriSema Phase 3 (REDEFINE 1): 25.3 % CagriSema thus becomes the largest body-weight signal reported in the published incretin literature to date , stronger than Tirzepatide (22.5 % in SURMOUNT-1) and comparable to Retatrutide
Dozens of Conagras Healthy Choice frozen meals are labeled as "GLP-1 friendly" through the companys On Track badge, indicating that theyre high in protein, low-calorie, and good sources of fiber
If you're injecting at 10 PM but scrolling your phone until midnight and getting fragmented sleep, you've destroyed the slow-wave sleep window where the GH pulse matters most
You are encouraged to report adverse events or adverse reactions to GLP-1 drugs to the FDA